- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/81 - Protease inhibitors
Patent holdings for IPC class C07K 14/81
Total number of patents in this class: 1172
10-year publication summary
|
83
|
100
|
81
|
84
|
102
|
111
|
90
|
82
|
80
|
38
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1157 |
35 |
| Angiochem Inc. | 42 |
24 |
| Daiichi Sankyo Company, Limited | 1874 |
20 |
| Translate bio, Inc. | 415 |
19 |
| The Regents of the University of California | 19929 |
18 |
| Avacta Life Sciences Limited | 34 |
18 |
| Takeda Pharmaceutical Company Limited | 2709 |
16 |
| Cytonics Corporation | 24 |
15 |
| Sanofi Aatd Inc. | 17 |
15 |
| CSL Behring GmbH | 345 |
13 |
| Serpin Pharma, LLC | 21 |
12 |
| Biotissue Holdings Inc. | 81 |
12 |
| Genentech, Inc. | 3980 |
11 |
| ProThera Biologics, Inc. | 22 |
10 |
| The Board of Trustees of the Leland Stanford Junior University | 6416 |
9 |
| Omeros Corporation | 307 |
9 |
| 3B Pharmaceuticals GmbH | 44 |
8 |
| University of Massachusetts | 2227 |
8 |
| Clara Foods Co., AKA Clara Foods | 98 |
8 |
| Azitra, Inc. | 42 |
8 |
| Other owners | 884 |